antibodi
immun
respons
dromedari
vaccin
mer
assess
euroimmun
elisa
kit
seroneg
calv
either
immunis
control
inject
pb
egfp
group
c
open
circl
mer
group
v
green
close
circl
seroposit
camel
either
immunis
control
inject
pb
egfp
group
c
open
squar
mer
group
v
red
close
squar
serum
sampl
differ
day
post
immunis
dpi
evalu
euroimmun
elisa
kit
infecti
camel
use
natur
challeng
model
also
evalu
black
squar
data
plot
challeng
c
challeng
b
timepoint
shown
dpi
day
post
boost
dpb
day
post
challeng
dpc
year
seroposit
seroneg
c
control
group
v
vaccin
group
viru
titr
merscov
infecti
camel
use
natur
infect
model
evalu
day
post
challeng
dpc
use
standard
curv
base
rtqpcr
assay
report
merscov
ge
tcid
ml
dot
line
repres
detect
limit
assay
determin
graph
b
b
viral
rna
sampl
known
tcid
ml
titr
utilis
set
standard
curv
rtqpcr
evalu
merscov
ge
tcid
ml
titr
detect
limit
assay
consid
valu
last
dilut
plateau
curv
colour
circl
squar
symbol
indic
valu
neg
sampl
healthi
camel
human
respect
dpc
ad
score
nasal
discharg
report
twenti
camel
experiment
group
c
v
c
v
dpc
e
score
ten
natur
infecti
camel
use
challeng
model
f
averag
score
per
group
score
record
arbitrari
unit
normal
recov
mild
moder
sever
depend
nasal
discharg
abund
statist
analysi
area
curv
score
present
figur
seroposit
seroneg
c
control
group
v
vaccin
group
co
cohous
camel
seroneg
dromedari
calv
year
old
immunis
pb
group
black
triangl
mer
group
blue
squar
older
calv
year
old
immunis
mer
group
red
circl
antispik
antibodi
level
assess
endpoint
titr
elisa
euroimmun
elisa
kit
b
correl
valu
assay
present
c
linear
regress
antibodi
titr
endpoint
elisa
euroimmun
elisa
ratio
show
signific
relationship
r
p
signific
correl
pearson
r
p
photograph
taken
cours
studi
refer
articl
must
made
cite
share
photo
note
group
v
also
call
c
also
call
v
also
call
c
also
call
c
control
v
vaccin
seroposit
n
seroneg
cohen
f
use
measur
practic
signific
test
report
local
effect
size
cohen
f
repeatedmeasur
